Viewing Study NCT02152761

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:13 PM
Ignite Modification Date: 2026-02-24 @ 2:30 PM
Study NCT ID: NCT02152761
Status: COMPLETED
Last Update Posted: 2020-08-19
First Post: 2014-05-08
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Study of Efficacy and Safety of Bimagrumab in Patients After Hip Fracture Surgery
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Muscle Wasting (Atrophy) After Hip Fracture Surgery View
Keywords:

Keywords

Keyword Brief Keyword Text View
None bimagrumab View
None BYM338 View
None hip fracture View
None elderly View
None controlled clinical trial View
None randomized View
None muscle wasting View
None atrophy View